IL127189A0 - Compositions methods and devices for the transdermal delivery of drugs - Google Patents

Compositions methods and devices for the transdermal delivery of drugs

Info

Publication number
IL127189A0
IL127189A0 IL12718997A IL12718997A IL127189A0 IL 127189 A0 IL127189 A0 IL 127189A0 IL 12718997 A IL12718997 A IL 12718997A IL 12718997 A IL12718997 A IL 12718997A IL 127189 A0 IL127189 A0 IL 127189A0
Authority
IL
Israel
Prior art keywords
drugs
devices
transdermal delivery
compositions methods
compositions
Prior art date
Application number
IL12718997A
Original Assignee
Diversified Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24616242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127189(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diversified Pharmaceuticals In filed Critical Diversified Pharmaceuticals In
Publication of IL127189A0 publication Critical patent/IL127189A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12718997A 1996-05-22 1997-05-22 Compositions methods and devices for the transdermal delivery of drugs IL127189A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65228096A 1996-05-22 1996-05-22
PCT/US1997/008636 WO1997043989A1 (en) 1996-05-22 1997-05-22 Compositions, methods and devices for the transdermal delivery of drugs

Publications (1)

Publication Number Publication Date
IL127189A0 true IL127189A0 (en) 1999-09-22

Family

ID=24616242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12718997A IL127189A0 (en) 1996-05-22 1997-05-22 Compositions methods and devices for the transdermal delivery of drugs

Country Status (6)

Country Link
EP (1) EP0954260A1 (en)
JP (1) JP2000513336A (en)
AU (1) AU3136897A (en)
CA (1) CA2256365A1 (en)
IL (1) IL127189A0 (en)
WO (1) WO1997043989A1 (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756053B2 (en) * 1995-07-28 2004-06-29 Zars, Inc. Controlled heat induced rapid delivery of pharmaceuticals from skin depot
US6284266B1 (en) * 1995-07-28 2001-09-04 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
DE19903241A1 (en) * 1999-01-28 2000-08-03 Merck Patent Gmbh Galenic wording
US6313370B1 (en) * 1999-04-29 2001-11-06 Morton Hyson Medicated wrap
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ES2283446T3 (en) * 2000-12-22 2007-11-01 DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL COMPOSITION OF GEL BASED ON ALCOHOL FOR THE TREATMENT OF HYPOGONADISM BY TRANSESCROTAL ADMINISTRATION.
JP5021124B2 (en) * 2001-08-29 2012-09-05 日東電工株式会社 Medical adhesive composition, medical adhesive tape and transdermal absorption tape formulation using the same
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
JP5295755B2 (en) 2005-03-24 2013-09-18 エモリー ユニバーシティー Dosing regimen for the treatment of traumatic brain injury with progesterone
US7473687B2 (en) * 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US7794407B2 (en) 2006-10-23 2010-09-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
NZ552816A (en) 2007-01-24 2009-05-31 Bomac Research Ltd Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US9636031B2 (en) 2007-11-26 2017-05-02 C.R. Bard, Inc. Stylets for use with apparatus for intravascular placement of a catheter
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US10449330B2 (en) 2007-11-26 2019-10-22 C. R. Bard, Inc. Magnetic element-equipped needle assemblies
US10524691B2 (en) 2007-11-26 2020-01-07 C. R. Bard, Inc. Needle assembly including an aligned magnetic element
CN103750858B (en) 2007-11-26 2017-04-12 C·R·巴德股份有限公司 Integrated system for intravascular placement of a catheter
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US10751509B2 (en) 2007-11-26 2020-08-25 C. R. Bard, Inc. Iconic representations for guidance of an indwelling medical device
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
EP2343963B1 (en) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
WO2010042612A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
WO2010042610A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
EP3542713A1 (en) 2009-06-12 2019-09-25 Bard Access Systems, Inc. Adapter for a catheter tip positioning device
WO2011019760A2 (en) 2009-08-10 2011-02-17 Romedex International Srl Devices and methods for endovascular electrography
US11103213B2 (en) 2009-10-08 2021-08-31 C. R. Bard, Inc. Spacers for use with an ultrasound probe
US9433641B2 (en) 2009-10-19 2016-09-06 Won Seog Choi Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
KR101133723B1 (en) * 2009-10-19 2012-04-09 최원석 Composition comprising salt and sugar for protecting and treating vaginosis disease and the use thereof
CZ302789B6 (en) 2009-11-25 2011-11-09 Zentiva, K. S. Method of increasing solubility of pharmaceutically active compounds and targeted (controlled) transport thereof into intestine
CN102821679B (en) 2010-02-02 2016-04-27 C·R·巴德股份有限公司 For the apparatus and method that catheter navigation and end are located
CA2800813C (en) 2010-05-28 2019-10-29 C.R. Bard, Inc. Apparatus for use with needle insertion guidance system
WO2012021542A2 (en) 2010-08-09 2012-02-16 C.R. Bard, Inc. Support and cover structures for an ultrasound probe head
EP2605699A4 (en) 2010-08-20 2015-01-07 Bard Inc C R Reconfirmation of ecg-assisted catheter tip placement
CN103189009B (en) 2010-10-29 2016-09-07 C·R·巴德股份有限公司 The bio-impedance auxiliary of Medical Devices is placed
CA2835890A1 (en) 2011-07-06 2013-01-10 C.R. Bard, Inc. Needle length determination and calibration for insertion guidance system
US10953025B2 (en) * 2011-07-14 2021-03-23 Able Cerebral, Llc Composition, device and method for delayed and sustained release of brain energy molecules
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
WO2013070775A1 (en) 2011-11-07 2013-05-16 C.R. Bard, Inc Ruggedized ultrasound hydrogel insert
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (en) 2011-11-23 2021-12-14 Therapeuticsmd, Inc A PHARMACEUTICAL COMPOSITION COMPRISING SOLUBILIZED ESTRADIOL, PROGESTERONE AND A SOLUBILIZING AGENT, AND USES THEREOF TO TREAT A MENOPAUSE-RELATED SYMPTOM IN A WOMAN
BR112014018439A8 (en) * 2012-01-26 2017-07-11 Therapeuticsmd Inc TRANSDERMAL HORMONE REPLACEMENT THERAPIES
CN104837413B (en) 2012-06-15 2018-09-11 C·R·巴德股份有限公司 Detect the device and method of removable cap on ultrasonic detector
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) * 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR102109188B1 (en) * 2013-04-01 2020-05-11 삼성전자주식회사 Temperature sensitive liposome comprising cationic lipid and use thereof
KR101470282B1 (en) * 2013-10-01 2014-12-05 최원석 Pharmaceutical Composition comprising a combination of a salt and sugar for proventing or treating lax vagina syndrome or colpoxerosis disease and the use thereof
US9839372B2 (en) 2014-02-06 2017-12-12 C. R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
JP2017516768A (en) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Natural combination hormone replacement therapy and therapy
MX2016013693A (en) 2014-07-29 2017-10-31 Therapeuticsmd Inc Transdermal cream.
US10973584B2 (en) 2015-01-19 2021-04-13 Bard Access Systems, Inc. Device and method for vascular access
US10349890B2 (en) 2015-06-26 2019-07-16 C. R. Bard, Inc. Connector interface for ECG-based catheter positioning system
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US11000207B2 (en) 2016-01-29 2021-05-11 C. R. Bard, Inc. Multiple coil system for tracking a medical device
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR101887088B1 (en) * 2017-02-28 2018-08-09 (주)강앤박메디컬 Needle free solution injecting apparatus and method of needle free injecting solution using the same
KR101871886B1 (en) * 2017-11-20 2018-06-27 김선수 Non-smoking bracelet with pill receptacle
TR201808384A2 (en) * 2018-06-12 2018-07-23 Yahya Yagiz Kemikoglu PHARMACEUTICAL CARRIER HOURS
KR101995868B1 (en) * 2018-07-10 2019-07-03 김선수 Bracelet with pill storage structure
WO2020081373A1 (en) 2018-10-16 2020-04-23 Bard Access Systems, Inc. Safety-equipped connection systems and methods thereof for establishing electrical connections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery

Also Published As

Publication number Publication date
CA2256365A1 (en) 1997-11-27
EP0954260A1 (en) 1999-11-10
JP2000513336A (en) 2000-10-10
AU3136897A (en) 1997-12-09
WO1997043989A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
EG24044A (en) pharmaceutical formulation of omeprazole
IL127446A (en) Compositions and methods for coating medical devices
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AU4534593A (en) Compositions and methods for enhanced drug delivery
AU3126797A (en) Intraosseous drug delivery device and method
EP0776215A4 (en) Device for delivery of substances and methods of use thereof
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
HUP0001748A3 (en) Transdermal device for the delivery of testosterone
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EP0941039A4 (en) Transdermal administration of ment
IL138888A0 (en) Pharmaceutical composition and combination preparation for immunosuppressive therapy
IL211081A0 (en) Methods and devices for providing prolonged drug therapy
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
EP0683668A4 (en) Compositions and methods for transdermal drug delivery.
AU3170697A (en) Transdermal drug delivery device for the delivery of tropisetron or granisetron
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
GB9700737D0 (en) Administration of drugs
EP0987942A4 (en) Pharmaceutical composition and methods for using it
HUP9802299A3 (en) Transdermal device for the delivery of alfuzosin
IL127281A0 (en) Novel devices for transdermal administering of trimegestone
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9625171D0 (en) Pharmaceutical compositions and devices for their administration